Search
for
Sort by
Research 31–60 of 101
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study
- Molecular pathology of skin adnexal tumours
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Biology of Human Hair: Know Your Hair to Control It
- Dermoscopy: not just for dermatologists
- Role of the Wnt signaling pathway in keratoacanthoma
- Dermatologic Adverse Events from Cancer Treatments
- The Potential Application of Exosomes as Therapeutic Agents, Carriers, and Biomarkers in Skin Diseases
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- British Hair and Nail Society
- Dermatological Drugs, Topical Agents, and Cosmetics
- Updates from the British Association of Dermatologists 91st Annual Meeting, 5-7 July 2011, London, U.K.
- Dermoscopy — 4th Conference of the Section of Dermoscopy and Other Skin Imaging Techniques (DiTOS) of the Polish Dermatological Society — Abstracts
- The senescence-like activity of BMS-470539 is associated with anti-fibrotic actions in models of dermal fibrosis
- Hair Changes due to Drugs
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Medications
- B‐ RAF , naevi and melanoma: a complex relationship
- Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib
- Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients.
- A cross-sectional study of clinical, dermoscopic, histopathological, and molecular patterns of scalp melanoma in patients with or without androgenetic alopecia
- BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer
- Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis
- Wound healing with topical BRAF inhibitor therapy in a diabetic model suggests tissue regenerative effects
- Resolution of paraneoplastic alopecia areata following nivolumab in a patient with metastatic melanoma
- The Dual Nature of Cellular Senescence: From Aging Signature to Regenerative Catalyst
- Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells
- Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
- Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression